Curesponse Ltd.

CRESPONSE

Diagnostic testing materials, namely, specialized tissue culture medical purposes; medical diagnostic reagents and assays for testing of tissue cultures and biological cultures; medical diagnostic reagents and assays for testing of body fluids; diagnostic test reagents for medical use for testing human cancer tissue; biological preparations for diagnostic purposes for medical purposes; diagnostic agents for medical and pharmaceutical purposes; diagnostic substances for medical purposes; medical diagnostic test strips for cancer analysis; diagnostic kits comprising of medical diagnostic agents, preparations and substances for medical purposes, namely, predicting response to cancer treatment; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; assay samples for medical and pharmaceutical use; biological tissue cultures for medical purposes;Laboratory testing in the nature of analysis in the field of cancer testing and pathology; medical laboratory services; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical product evaluation; providing testing services and information for diagnosis, prognosis and predictive behavior of cancer for research purposes;

CRESPONSE

C RESPONSE; SEE RESPONSE; CURE RESPONSE;Medical testing for diagnostic or treatment purposes; Providing medical testing services in the field of diagnosis and treatment of cancer diseases; medical testing services for diagnostic or treatment purposes in the field of optimization of pharmaceutical treatment for cancer patients; provision of medical information in the field of cancer screening, diagnosis and treatment; health care services for treating cancer;